Insider Trading History of Pardeep Nijhawan Medicine Professional Corp

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Pardeep Nijhawan Medicine Professional Corp since 2020. This trader's CIK number is 1780021. At the time of last reporting, Pardeep Nijhawan Medicine Professional Corp was the Officer of Edesa Biotech, Inc.. (stock ticker symbol EDSA). Also see all insider trading activities at Edesa Biotech, Inc..


Yearly summary of insider trading at Edesa Biotech, Inc. (EDSA) by Pardeep Nijhawan Medicine Professional Corp

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 EDSA 5,000 $20,000 0 $0 0 $0
2022 EDSA 47,500 $109,598 0 $0 0 $0
2020 EDSA 10,000 $52,010 0 $0 0 $0
2020 EDSA 8,000 $18,315 0 $0 0 $0


Insider trading of Edesa Biotech, Inc. (EDSA) by Pardeep Nijhawan Medicine Professional Corp

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-03-25 EDSA Buy 5,000 4.00 20,000
2022-06-30 EDSA Buy 20,000 1.60 32,080
2022-05-27 EDSA Buy 5,000 1.92 9,600
2022-05-24 EDSA Buy 2,000 1.80 3,600
2022-03-31 EDSA Buy 2,000 2.99 5,972
2022-03-30 EDSA Buy 2,000 3.05 6,098
2022-03-29 EDSA Buy 2,000 3.02 6,034
2022-03-18 EDSA Buy 2,000 3.85 7,700
2022-03-17 EDSA Buy 2,000 3.26 6,514
2022-03-15 EDSA Buy 2,000 2.80 5,598
2022-03-11 EDSA Buy 7,000 3.12 21,833
2022-03-09 EDSA Buy 1,500 3.05 4,569
2020-03-29 EDSA Buy 2,000 5.23 10,460
2021-03-25 EDSA Buy 3,000 5.25 15,750
2021-03-24 EDSA Buy 5,000 5.16 25,800
2020-05-26 EDSA Buy 3,000 2.98 8,940
2020-03-17 EDSA Buy 5,000 1.88 9,375

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pardeep Nijhawan Medicine Professional Corp (Officer of Edesa Biotech, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.